FDA warned Julian Naya Beauty LLC that it sells six unapproved injectable fat-dissolving drugs on its website and social media.
What happened
FDA reviewed the company's website (juliannayabeauty.com) in January 2025, along with its Facebook and Instagram pages, which point consumers to the site to buy the products. FDA found six injectable fat-dissolving products offered for sale with claims that they remove fat, treat obesity or reshape the face and body. FDA says none of the products has an FDA-approved application, so selling them makes them unapproved new drugs.
What FDA found
The company sells injectable drug products with no FDA-approved application, which is illegal.
Sections 301(d) and 505(a) of the FD&C Act, 21 U.S.C. 331(d) and 355(a)The products are not generally recognized as safe and effective for the uses claimed, so they count as "new drugs" that need FDA approval.
Section 201(p) of the FD&C Act, 21 U.S.C. 321(p)Website and social media claims (fat removal, obesity treatment, facial contouring) show the products are intended to affect the body, making them drugs.
Section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)
What FDA wants
The company must write to FDA within fifteen working days describing the specific steps taken to correct the violations and prevent recurrence, with supporting documents. If corrections cannot be finished in that time, it must explain why and give a completion date.
Who should pay attention
- med spas and aesthetic clinics offered these injectables
- consumers buying fat-dissolving injections online
- distributors and fulfillment firms handling imported injectables
This is a summary. Read the original letter on fda.gov.